Comparación de la efectividad de la toxina botulínica y solución salina en la función del tobillo en pacientes con gastrocnemios cortos: ensayo clínico controlado
Carlos Alonso Reynoso-Mendoza, David Muñoz-Leija, Fernando Alfredo Fernández-Garza, Luis Alberto Moya-Estrada, Abraham Guadalupe Espinosa-Uribe · Orthotips AMOT · 2024
Not cached yet. This record was fetched live for this request and is stored after the lookup. Reopening the page should serve the cached copy.
Orthotips AMOT · OpenAlex · article · 2024
Abstract
Introduction: the short gastrocnemius muscles are responsible for plantar pain and are a contributing factor in various pathologies, such as plantar fasciitis, hallux valgus, hallux limitus, metatarsalgia, and Achilles tendonitis.Objective: this study aims to compare ankle function changes following botulinum toxin versus saline solution injections in adults with non-spastic short gastrocnemius muscles.Material and methods: in this controlled clinical trial, adult participants diagnosed with short gastrocnemius muscles using the Silfverskiold test were randomized into two groups.The experimental group received intramuscular botulinum toxin injections, while the control group received saline solution injections.Demographics were recorded.Pre-intervention and 4-week post-intervention assessments included Maryland and American Orthopaedic Foot and Ankle Society (AOFAS) questionnaires.Results: the study included 18 patients, equally divided into two groups.Cavus feet were common.Baseline Maryland scores were 59.7 ± 4.4 in the experimental group and 58.8 ± 5.9 in the control group, increasing to 67.6 ± 4.3 and 60.5 ± 6.3 post-intervention, respectively (p = 0.01).AOFAS scores in the experimental group were 70.2 ± 9.6 at baseline and 81.5 ± 8.3 post-intervention, while the control group had scores of 73.0 ± 9.4 and 74.6 ± 9.0, with no statistically significant differences.Conclusion: botulinum toxin presents a viable treatment option for short gastrocnemius muscles, leading to improved functionality and symptom reduction in adults.
Open the resolved locator · 10.35366/116338
Metadata licence: OpenAlex metadata (CC0)